nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—Graves' disease	0.712	1	CbGaD
Epinephrine—CYP1A2—Methimazole—Graves' disease	0.101	0.412	CbGbCtD
Epinephrine—CYP2C9—Methimazole—Graves' disease	0.0909	0.372	CbGbCtD
Epinephrine—CYP3A4—Methimazole—Graves' disease	0.0529	0.216	CbGbCtD
Epinephrine—TNF—Caspase Cascade in Apoptosis—FASLG—Graves' disease	0.000309	0.00719	CbGpPWpGaD
Epinephrine—TNF—Caspase Cascade in Apoptosis—FAS—Graves' disease	0.000298	0.00694	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—Graves' disease	0.000292	0.0068	CbGpPWpGaD
Epinephrine—TNF—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000281	0.00654	CbGpPWpGaD
Epinephrine—TNF—Monoamine Transport—IL1B—Graves' disease	0.000277	0.00644	CbGpPWpGaD
Epinephrine—TNF—IL23-mediated signaling events—IFNG—Graves' disease	0.000276	0.00643	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—FASLG—Graves' disease	0.000275	0.0064	CbGpPWpGaD
Epinephrine—TNF—Toll-like Receptor Signaling Pathway—CD40—Graves' disease	0.000272	0.00634	CbGpPWpGaD
Epinephrine—ADRB1—G alpha (s) signalling events—TSHR—Graves' disease	0.000272	0.00632	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—HLA-DQB1—Graves' disease	0.000271	0.00631	CbGpPWpGaD
Epinephrine—TNF—IL23-mediated signaling events—CD4—Graves' disease	0.000267	0.00621	CbGpPWpGaD
Epinephrine—ADRB2—G alpha (s) signalling events—TSHR—Graves' disease	0.000266	0.00619	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—IL2RA—Graves' disease	0.000263	0.00613	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000261	0.00608	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—HLA-A—Graves' disease	0.000261	0.00606	CbGpPWpGaD
Epinephrine—TNF—IL23-mediated signaling events—IL1B—Graves' disease	0.000246	0.00573	CbGpPWpGaD
Epinephrine—ADRBK1—CXCR4-mediated signaling events—CD4—Graves' disease	0.000245	0.0057	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—HLA-B—Graves' disease	0.000243	0.00567	CbGpPWpGaD
Epinephrine—TNF—Toll-like Receptor Signaling Pathway—CXCL10—Graves' disease	0.000243	0.00566	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000243	0.00566	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—FASLG—Graves' disease	0.000238	0.00554	CbGpPWpGaD
Epinephrine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	0.000232	0.0054	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—FAS—Graves' disease	0.000229	0.00534	CbGpPWpGaD
Epinephrine—TNF—Alzheimers Disease—FAS—Graves' disease	0.000229	0.00534	CbGpPWpGaD
Epinephrine—TNF—Folate Metabolism—ICAM1—Graves' disease	0.000228	0.00532	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—IL2RA—Graves' disease	0.000228	0.00531	CbGpPWpGaD
Epinephrine—TNF—Apoptosis—FASLG—Graves' disease	0.000227	0.00527	CbGpPWpGaD
Epinephrine—ADRBK1—DAP12 interactions—HLA-B—Graves' disease	0.000226	0.00526	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—HLA-A—Graves' disease	0.000226	0.00525	CbGpPWpGaD
Epinephrine—TNF—Apoptosis—FAS—Graves' disease	0.000218	0.00509	CbGpPWpGaD
Epinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000218	0.00508	CbGpPWpGaD
Epinephrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Graves' disease	0.000217	0.00505	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—CXCL10—Graves' disease	0.000217	0.00504	CbGpPWpGaD
Epinephrine—PAH—SIDS Susceptibility Pathways—IL1B—Graves' disease	0.000216	0.00504	CbGpPWpGaD
Epinephrine—TNF—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000214	0.00497	CbGpPWpGaD
Epinephrine—TNF—Regulation of toll-like receptor signaling pathway—CD40—Graves' disease	0.000213	0.00495	CbGpPWpGaD
Epinephrine—TNF—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	0.000207	0.00482	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—HLA-DRB1—Graves' disease	0.000206	0.0048	CbGpPWpGaD
Epinephrine—TNF—TGF-beta Receptor Signaling—IFNG—Graves' disease	0.000204	0.00475	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—GABRA3—Graves' disease	0.0002	0.00466	CbGpPWpGaD
Epinephrine—TNF—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000191	0.00444	CbGpPWpGaD
Epinephrine—TNF—Regulation of toll-like receptor signaling pathway—CXCL10—Graves' disease	0.00019	0.00442	CbGpPWpGaD
Epinephrine—PAH—Metabolism—GC—Graves' disease	0.000188	0.00437	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—GABRA3—Graves' disease	0.000186	0.00434	CbGpPWpGaD
Epinephrine—TNF—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000181	0.00422	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—Graves' disease	0.000174	0.00405	CbGpPWpGaD
Epinephrine—TNF—Folate Metabolism—IFNG—Graves' disease	0.000174	0.00405	CbGpPWpGaD
Epinephrine—SLC22A5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000171	0.00398	CbGpPWpGaD
Epinephrine—PAH—Disease—B3GNT2—Graves' disease	0.00017	0.00395	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—TSHR—Graves' disease	0.000166	0.00387	CbGpPWpGaD
Epinephrine—PAH—SIDS Susceptibility Pathways—TNF—Graves' disease	0.000157	0.00366	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—IFIH1—Graves' disease	0.000157	0.00365	CbGpPWpGaD
Epinephrine—TNF—Folate Metabolism—IL1B—Graves' disease	0.000155	0.00361	CbGpPWpGaD
Epinephrine—TNF—Adipogenesis—FAS—Graves' disease	0.000154	0.00359	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—IFNG—Graves' disease	0.000151	0.0035	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—ICAM1—Graves' disease	0.000144	0.00334	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000142	0.00331	CbGpPWpGaD
Epinephrine—PAH—Metabolism—B3GNT2—Graves' disease	0.000142	0.00331	CbGpPWpGaD
Epinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	0.000141	0.00328	CbGpPWpGaD
Epinephrine—TNF—Apoptosis—FASLG—Graves' disease	0.000139	0.00323	CbGpPWpGaD
Epinephrine—TNF—Selenium Micronutrient Network—IFNG—Graves' disease	0.000138	0.00321	CbGpPWpGaD
Epinephrine—TNF—Alzheimers Disease—IL1B—Graves' disease	0.000134	0.00313	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—IL1B—Graves' disease	0.000134	0.00313	CbGpPWpGaD
Epinephrine—TNF—Apoptosis—FAS—Graves' disease	0.000134	0.00312	CbGpPWpGaD
Epinephrine—TNF—MAPK Signaling Pathway—FASLG—Graves' disease	0.00013	0.00303	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00013	0.00301	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000128	0.00299	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000127	0.00295	CbGpPWpGaD
Epinephrine—TNF—MAPK Signaling Pathway—FAS—Graves' disease	0.000125	0.00292	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—HLA-E—Graves' disease	0.000123	0.00287	CbGpPWpGaD
Epinephrine—TNF—Selenium Micronutrient Network—IL1B—Graves' disease	0.000123	0.00287	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.00012	0.00279	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000118	0.00275	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000117	0.00273	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—TSHR—Graves' disease	0.000117	0.00272	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000113	0.00264	CbGpPWpGaD
Epinephrine—TNF—Toll-like Receptor Signaling Pathway—IL1B—Graves' disease	0.000109	0.00255	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—IFNG—Graves' disease	0.000109	0.00254	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—TSHR—Graves' disease	0.000108	0.00252	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—B3GNT2—Graves' disease	0.000108	0.00252	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000108	0.0025	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—CXCL10—Graves' disease	0.000107	0.0025	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—TSHR—Graves' disease	0.000106	0.00247	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	0.000105	0.00244	CbGpPWpGaD
Epinephrine—ADRA2B—G alpha (i) signalling events—CXCL10—Graves' disease	0.000104	0.00243	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.0001	0.00233	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—TSHR—Graves' disease	9.86e-05	0.0023	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—TSHR—Graves' disease	9.77e-05	0.00227	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—CXCL10—Graves' disease	9.74e-05	0.00227	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—IL1B—Graves' disease	9.74e-05	0.00227	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—Graves' disease	9.74e-05	0.00227	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—TSHR—Graves' disease	9.65e-05	0.00225	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—TSHR—Graves' disease	9.39e-05	0.00219	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	9.18e-05	0.00214	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—TSHR—Graves' disease	9.13e-05	0.00212	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IFIH1—Graves' disease	9.12e-05	0.00212	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—TSHR—Graves' disease	8.98e-05	0.00209	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—HLA-B—Graves' disease	8.78e-05	0.00204	CbGpPWpGaD
Epinephrine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—Graves' disease	8.54e-05	0.00199	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—TSHR—Graves' disease	8.53e-05	0.00198	CbGpPWpGaD
Epinephrine—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	8.37e-05	0.00195	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	8.37e-05	0.00195	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	8.29e-05	0.00193	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	8.19e-05	0.00191	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	8.12e-05	0.00189	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—TSHR—Graves' disease	7.98e-05	0.00186	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—CXCL10—Graves' disease	7.91e-05	0.00184	CbGpPWpGaD
Epinephrine—ADRA2C—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	7.82e-05	0.00182	CbGpPWpGaD
Epinephrine—TNF—SIDS Susceptibility Pathways—IL1B—Graves' disease	7.79e-05	0.00181	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	7.75e-05	0.0018	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	7.62e-05	0.00177	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—CXCL10—Graves' disease	7.56e-05	0.00176	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—TSHR—Graves' disease	7.41e-05	0.00173	CbGpPWpGaD
Epinephrine—TNF—MAPK Signaling Pathway—IL1B—Graves' disease	7.34e-05	0.00171	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	7.24e-05	0.00169	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HLA-E—Graves' disease	7.18e-05	0.00167	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD40—Graves' disease	7.02e-05	0.00163	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—CXCL10—Graves' disease	6.99e-05	0.00163	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CTLA4—Graves' disease	6.91e-05	0.00161	CbGpPWpGaD
Epinephrine—PAH—Disease—HLA-A—Graves' disease	6.87e-05	0.0016	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—CXCL10—Graves' disease	6.86e-05	0.0016	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	6.77e-05	0.00158	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—CXCL10—Graves' disease	6.37e-05	0.00148	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	6.35e-05	0.00148	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—CXCL10—Graves' disease	6.31e-05	0.00147	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—Graves' disease	6.29e-05	0.00146	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TSHR—Graves' disease	6.27e-05	0.00146	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—CXCL10—Graves' disease	6.23e-05	0.00145	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.21e-05	0.00145	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—TSHR—Graves' disease	6.12e-05	0.00142	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—CXCL10—Graves' disease	6.07e-05	0.00141	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—CXCL10—Graves' disease	5.9e-05	0.00137	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—CXCL10—Graves' disease	5.8e-05	0.00135	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—IL2RA—Graves' disease	5.78e-05	0.00134	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HLA-DQB1—Graves' disease	5.69e-05	0.00133	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—TSHR—Graves' disease	5.57e-05	0.0013	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—TSHR—Graves' disease	5.55e-05	0.00129	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—TSHR—Graves' disease	5.52e-05	0.00129	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—CXCL10—Graves' disease	5.51e-05	0.00128	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—TSHR—Graves' disease	5.45e-05	0.00127	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GC—Graves' disease	5.42e-05	0.00126	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD8A—Graves' disease	5.32e-05	0.00124	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	5.31e-05	0.00124	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GC—Graves' disease	5.27e-05	0.00123	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	5.26e-05	0.00122	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	5.26e-05	0.00122	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL2RA—Graves' disease	5.25e-05	0.00122	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—CD4—Graves' disease	5.24e-05	0.00122	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—TSHR—Graves' disease	5.16e-05	0.0012	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—CXCL10—Graves' disease	5.16e-05	0.0012	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HLA-B—Graves' disease	5.11e-05	0.00119	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—TSHR—Graves' disease	5.08e-05	0.00118	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—TSHR—Graves' disease	5.06e-05	0.00118	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GC—Graves' disease	5.05e-05	0.00118	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TSHR—Graves' disease	5.04e-05	0.00117	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—TSHR—Graves' disease	5.01e-05	0.00117	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—TSHR—Graves' disease	4.95e-05	0.00115	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL2RA—Graves' disease	4.79e-05	0.00112	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—CXCL10—Graves' disease	4.79e-05	0.00112	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HLA-A—Graves' disease	4.74e-05	0.0011	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—TSHR—Graves' disease	4.68e-05	0.00109	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—IL2RA—Graves' disease	4.64e-05	0.00108	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—TSHR—Graves' disease	4.61e-05	0.00107	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—TSHR—Graves' disease	4.51e-05	0.00105	CbGpPWpGaD
Epinephrine—PAH—Disease—CD4—Graves' disease	4.42e-05	0.00103	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HLA-A—Graves' disease	4.38e-05	0.00102	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HLA-DRB1—Graves' disease	4.33e-05	0.00101	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—IL2RA—Graves' disease	4.32e-05	0.001	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GC—Graves' disease	4.28e-05	0.000996	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL2RA—Graves' disease	4.21e-05	0.00098	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—TSHR—Graves' disease	4.19e-05	0.000975	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—ICAM1—Graves' disease	4.16e-05	0.000967	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—B3GNT2—Graves' disease	4.11e-05	0.000956	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—TSHR—Graves' disease	4.09e-05	0.000953	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CXCL10—Graves' disease	4.05e-05	0.000944	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—IL2RA—Graves' disease	4.03e-05	0.000938	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—B3GNT2—Graves' disease	3.99e-05	0.00093	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CXCL10—Graves' disease	3.95e-05	0.00092	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—B3GNT2—Graves' disease	3.83e-05	0.000891	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—TSHR—Graves' disease	3.8e-05	0.000886	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CXCL10—Graves' disease	3.6e-05	0.000838	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CXCL10—Graves' disease	3.59e-05	0.000836	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CXCL10—Graves' disease	3.57e-05	0.000831	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CXCL10—Graves' disease	3.52e-05	0.00082	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CXCL10—Graves' disease	3.33e-05	0.000776	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TSHR—Graves' disease	3.28e-05	0.000764	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CXCL10—Graves' disease	3.28e-05	0.000764	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—IL2RA—Graves' disease	3.27e-05	0.000762	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CXCL10—Graves' disease	3.27e-05	0.000761	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CXCL10—Graves' disease	3.25e-05	0.000758	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—B3GNT2—Graves' disease	3.24e-05	0.000755	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CXCL10—Graves' disease	3.24e-05	0.000754	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CXCL10—Graves' disease	3.2e-05	0.000745	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IFNG—Graves' disease	3.16e-05	0.000736	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL2RA—Graves' disease	3.1e-05	0.000721	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD4—Graves' disease	3.05e-05	0.000711	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CXCL10—Graves' disease	3.03e-05	0.000705	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—IL2RA—Graves' disease	3.02e-05	0.000703	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TSHR—Graves' disease	2.99e-05	0.000696	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CXCL10—Graves' disease	2.98e-05	0.000693	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TSHR—Graves' disease	2.96e-05	0.00069	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TSHR—Graves' disease	2.92e-05	0.000681	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CXCL10—Graves' disease	2.91e-05	0.000678	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL1B—Graves' disease	2.82e-05	0.000657	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—CD4—Graves' disease	2.82e-05	0.000656	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TSHR—Graves' disease	2.77e-05	0.000644	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GC—Graves' disease	2.77e-05	0.000644	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2RA—Graves' disease	2.75e-05	0.000641	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2RA—Graves' disease	2.74e-05	0.000639	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2RA—Graves' disease	2.73e-05	0.000635	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TSHR—Graves' disease	2.72e-05	0.000634	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCL10—Graves' disease	2.71e-05	0.00063	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2RA—Graves' disease	2.69e-05	0.000627	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCL10—Graves' disease	2.65e-05	0.000616	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2RA—Graves' disease	2.55e-05	0.000593	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2RA—Graves' disease	2.51e-05	0.000584	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2RA—Graves' disease	2.5e-05	0.000582	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2RA—Graves' disease	2.49e-05	0.000579	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2RA—Graves' disease	2.48e-05	0.000577	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCL10—Graves' disease	2.46e-05	0.000572	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2RA—Graves' disease	2.45e-05	0.000569	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TSHR—Graves' disease	2.42e-05	0.000563	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GC—Graves' disease	2.36e-05	0.00055	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2RA—Graves' disease	2.31e-05	0.000539	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2RA—Graves' disease	2.28e-05	0.00053	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TSHR—Graves' disease	2.25e-05	0.000523	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2RA—Graves' disease	2.23e-05	0.000518	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL10—Graves' disease	2.12e-05	0.000494	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—B3GNT2—Graves' disease	2.1e-05	0.000488	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2RA—Graves' disease	2.07e-05	0.000482	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2RA—Graves' disease	2.02e-05	0.000471	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL10—Graves' disease	1.93e-05	0.00045	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL10—Graves' disease	1.91e-05	0.000446	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL10—Graves' disease	1.89e-05	0.00044	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2RA—Graves' disease	1.88e-05	0.000437	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GC—Graves' disease	1.82e-05	0.000425	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—B3GNT2—Graves' disease	1.79e-05	0.000417	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL10—Graves' disease	1.79e-05	0.000416	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL10—Graves' disease	1.76e-05	0.00041	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2RA—Graves' disease	1.62e-05	0.000377	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL10—Graves' disease	1.56e-05	0.000364	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2RA—Graves' disease	1.48e-05	0.000344	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2RA—Graves' disease	1.46e-05	0.000341	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL10—Graves' disease	1.45e-05	0.000338	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2RA—Graves' disease	1.44e-05	0.000336	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.38e-05	0.000322	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2RA—Graves' disease	1.37e-05	0.000318	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2RA—Graves' disease	1.35e-05	0.000313	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2RA—Graves' disease	1.19e-05	0.000278	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2RA—Graves' disease	1.11e-05	0.000258	CbGpPWpGaD
